Floatz logo

NEOMYCIN

Surgical Site Infection

Helsinki University Central HospitalmixturePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Surgical Site Infection cohort.

Asset / SponsorPhaseRating
MACROGOLS
Helsinki University Central Hospital
Phase 4BBB
METRONIDAZOLE
Helsinki University Central Hospital
Phase 4BBB
Activematrix
Baylor College of Medicine
Phase 4BB
TOCOPHEROL ACETATE
Hospital General Universitario Elche
Phase 3BB
Alpha Tocopherol
Hospital General Universitario Elche
Phase 3B

View all 13 →

Same molecule, other indications

NEOMYCIN is also rated in:

Rectum NeoplasmDormant
BB
Indicative ·
65 / 100
View asset →
Surgery--ComplicationsDormant
BB
Indicative ·
65 / 100
View asset →
Metastatic Colorectal Cancer or Head and Neck Squamous Cell CarcinomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →